This is the authors' abstract. We don't add key points for this paper.
This paper presents a study of designing phase-specific and -mixed Ir–Ru–Mn trimetallic electrocatalysts with enhanced performance. By changing the content of Ru, the alloy electrocatalyst evolved from a face-centered tetragonal (fct) phase to a mixture of fct and hexagonal close-packed (hcp) phases and finally to the hcp phase. Among these trimetallic systems, the hcp-phase Ir 0.23 Ru 0.20 Mn 0.57 electrocatalyst (Ru/Ir = 0.47:0.53) delivered the best performance toward the oxygen evolution reaction (OER), achieving an overpotential of 226 mV at 10 mA cm –2 and a Tafel slope of ∼46.8 mV dec –1 . Interestingly, this low-Ir hcp-phase catalyst maintained stable operation for >57 h at a current density of 100 mA cm –2 in 0.1 M HClO 4, whereas the Ir-rich fct-phase counterpart (Ir 0.35 Ru 0.07 Mn 0.58 ) degraded within 22 h under identical conditions. Potentiodynamic polarization curve study indicated that oxidative dissolution is the dominant degradation pathway, and the structural characterizations indicated that the hcp-phase alloy remained intact, while rutile-type IrRuMnO x oxide was formed for the fct-phase alloy electrocatalyst. These results underscore the effect of the crystal phase on OER durability of the electrocatalyst and point to a design strategy for improving the durability of OER electrocatalysts without increasing the Ir content.
No takes yet. Share an insight, caveat, or question.
Song et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: